Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 67301 - 67325 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Rosiglitazone	Approved Investigational	SPARCL1	8404	downregulated	rosiglitazone results in decreased expression of SPARCL1 mRNA	4q22.1	A22609
Rosiglitazone	Approved Investigational	SPINK1	6690	upregulated	rosiglitazone results in increased expression of SPINK1 mRNA	5q32	A22609
Rosiglitazone	Approved Investigational	SPP2	6694	downregulated	rosiglitazone results in decreased expression of SPP2 mRNA	2q37.1	A22609
Rosiglitazone	Approved Investigational	SREBF1	6720	upregulated	rosiglitazone results in increased expression of SREBF1 mRNA	17p11.2	A24116
Rosiglitazone	Approved Investigational	SRPX	8406	upregulated	rosiglitazone results in increased expression of SRPX mRNA	Xp11.4	A22609
Rosiglitazone	Approved Investigational	SRXN1	140809	upregulated	rosiglitazone results in increased expression of SRXN1 mRNA	20p13	A22609 A20427
Rosiglitazone	Approved Investigational	SSMEM1	136263	downregulated	rosiglitazone results in decreased expression of SSMEM1 mRNA	7q32.2	A10216
Rosiglitazone	Approved Investigational	ST6GAL1	6480	downregulated	rosiglitazone results in decreased expression of ST6GAL1 mRNA	3q27.3	A22609
Rosiglitazone	Approved Investigational	STAMBP	10617	downregulated	rosiglitazone results in decreased expression of STAMBP mRNA	2p13.1	A24100
Rosiglitazone	Approved Investigational	STAR	6770	upregulated	rosiglitazone results in increased expression of STAR mRNA	8p11.23	A24132
Rosiglitazone	Approved Investigational	STC1	6781	downregulated	rosiglitazone results in decreased expression of STC1 mRNA	8p21.2	A22609
Rosiglitazone	Approved Investigational	STX3	6809	upregulated	rosiglitazone results in increased expression of STX3 mRNA	11q12.1	A22609
Rosiglitazone	Approved Investigational	SULF2	55959	downregulated	rosiglitazone results in decreased expression of SULF2 mRNA	20q13.12	A20427
Rosiglitazone	Approved Investigational	SYT7	9066	downregulated	rosiglitazone results in decreased expression of SYT7 mRNA	11q12.2	A22609
Rosiglitazone	Approved Investigational	TACSTD2	4070	downregulated	rosiglitazone results in decreased expression of TACSTD2 mRNA	1p32.1	A10216
Rosiglitazone	Approved Investigational	TBC1D2	55357	upregulated	rosiglitazone results in increased expression of TBC1D2 mRNA	9q22.33	A10216
Rosiglitazone	Approved Investigational	TBL1X	6907	downregulated	rosiglitazone results in decreased expression of TBL1X mRNA	Xp22.31-p22.2	A10216
Rosiglitazone	Approved Investigational	TBL2	26608	upregulated	rosiglitazone results in increased expression of TBL2 mRNA	7q11.23	A10216
Rosiglitazone	Approved Investigational	TBXA2R	6915	downregulated	rosiglitazone results in decreased expression of TBXA2R mRNA alternative form	19p13.3	A24145
Rosiglitazone	Approved Investigational	TFF1	7031	upregulated	rosiglitazone results in increased expression of TFF1 mRNA	21q22.3	A21384
Rosiglitazone	Approved Investigational	TGFB1	7040	downregulated	rosiglitazone results in decreased expression of TGFB1 mRNA	19q13.1	A24146
Rosiglitazone	Approved Investigational	TGFB1	7040	upregulated	rosiglitazone results in increased expression of TGFB1 mRNA	19q13.1	A24100
Rosiglitazone	Approved Investigational	TGM2	7052	upregulated	rosiglitazone results in increased expression of TGM2 mRNA	20q11.23	A10216
Rosiglitazone	Approved Investigational	THBS3	7059	upregulated	rosiglitazone results in increased expression of THBS3 mRNA	1q22	A10216
Rosiglitazone	Approved Investigational	THRSP	7069	downregulated	rosiglitazone results in decreased expression of THRSP mRNA	11q14.1	A22609

Displaying entries 67301 - 67325 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability